Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-24T13:47:06.864Z Has data issue: false hasContentIssue false

Prolactin and Family Psychiatric History in Schizophrenia

Published online by Cambridge University Press:  19 July 2023

I. Bouguerra*
Affiliation:
F pyshciatry departement
E. Khelifa
Affiliation:
F pyshciatry departement
A. Adouni
Affiliation:
F pyshciatry departement
S. Sdiri
Affiliation:
F pyshciatry departement
H. Abaza
Affiliation:
Razi Hospital, Mannouba, Tunisia
H. Ben Ammar
Affiliation:
F pyshciatry departement
L. Mnif
Affiliation:
F pyshciatry departement
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Schizophrenia is a chronic and multifactorial mental disorder. Research suggests the presence of an abnormality in prolactin secretion during the genesis of the disease and at the same time, the involvement of genetics in its pathogenesis has long been the demand of researchers in the field of genetics since familial forms of schizophrenia have been observed.

Objectives

The objective of this study was to describe the prolactin profile and and to study its relationship to the patients’ family history of pyshciatric illness.

Methods

This was a descriptive, cross-sectional study of thirty male patients hospitalized for a psychotic relapse who were naïve or discontinuing treatment for at least two months. Patients were assessed using a semi-structured questionnaire. A blood sample was taken to measure levels of prolactin.

Results

The age ranged from 17 to 56 years. Most patients had a family medical history. Twenty patients (66%) had a family psychiatric history of schizophrenia (56%), mental retardation (3%), personality disorder (3%) and schizoaffective disorder (3%). Prolactin levels ranged from 0.5 to 45.67 ng/mL with a mean of 14.03 ng/mL. Seven patients (23%) had hyperprolactinaemia. All patients with hyperprolactinaemia had a family history of psychiatry with a statistically significant difference (p= 0.033).

Conclusions

Hyperprolactinemia could be one of the “endophenotypes” that reflect a vulnerability to schizophrenia, found in familial forms of the disease. In this context, longitudinal studies on a larger scale and family studies including siblings without schizophrenia should be undertaken.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.